The Center for State Control of Medicines, Equipment and Medical Devices (Cecmed by its Spanish acronym) granted the Conditional Sanitary Registration to Nasalferon, a nasal application solution for the prophylaxis of SARS-CoV-2 infection, the virus that causes COVID-19.